FCM
ALKS icon

Fieldview Capital Management’s Alkermes ALKS Stock Holding History

Fieldview Capital Management’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-52,943
Closed -$1.75M – 337
2025
Q1 		$1.75M Buy
52,943
+43,003
+433% +$1.4M 0.25% 151
2024
Q4 		$286K Buy
+9,940
New +$286K 0.04% 361

Other funds holding ALKS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fieldview Capital Management's ALKS Position: Q2 2025 in Review

Fieldview Capital Management sold out of Alkermes (ALKS) in Q2 2025, closing a stake of 52,943 shares — an estimated $1.75M sold.

Fieldview Capital Management first reported a position in ALKS in Q4 2024 and held it in 2 quarters. The position peaked at $1.75M in Q1 2025. 353 funds tracked by Wall St. Rank hold ALKS as of Q2 2025.

  • Fieldview Capital Management reported no remaining Alkermes position as of Q2 2025 after selling out during the quarter.
  • Fieldview Capital Management sold 52,943 Alkermes shares in Q2 2025, an estimated $1.75M.
  • Fieldview Capital Management first reported a position in Alkermes in Q4 2024 and held it in 2 quarters.
  • Fieldview Capital Management's Alkermes position peaked at $1.75M in Q1 2025.
  • 353 funds tracked by Wall St. Rank held Alkermes as of Q2 2025.

Based on Fieldview Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.